Cargando…
p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
The oncolytic adenovirus dl922-947 replicates selectively within and lyses cells with a dysregulated Rb pathway, a finding seen in > 90% human cancers. dl922-947 is more potent than wild type adenovirus and the E1B-deletion mutant dl1520 (Onyx-015). We wished to determine which host cell factors...
Autores principales: | Flak, Magdalena B, Connell, Claire M, Chelala, Claude, Archibald, Kyra, Salako, Michael A, Pirlo, Katrina J, Lockley, Michelle, Wheatley, Sally P, Balkwill, Frances R, McNeish, Iain A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904726/ https://www.ncbi.nlm.nih.gov/pubmed/20598155 http://dx.doi.org/10.1186/1476-4598-9-175 |
Ejemplares similares
-
Vaccinia Virus Induces Programmed Necrosis in Ovarian Cancer Cells
por: Whilding, Lynsey M, et al.
Publicado: (2013) -
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium
por: Archibald, Kyra M, et al.
Publicado: (2012) -
Strategies to Optimise Oncolytic Viral Therapies: The Role of Natural Killer Cells
por: Leung, Elaine Y. L., et al.
Publicado: (2021) -
Tropism-Modification Strategies for Targeted Gene Delivery Using Adenoviral Vectors
por: Coughlan, Lynda, et al.
Publicado: (2010) -
Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer
por: Ingemarsdotter, C K, et al.
Publicado: (2010)